Clinical Trial Update: Rare Group Problem Management Plus [NA]

View source ↗

Summary

Completed clinical trial update for the Rare Group Problem Management Plus program, evaluating anxiety, depressive symptoms, PTSD, and psychosocial problems.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Depressive Disorders
• Post-traumatic Stress Disorder

Snippet

Sponsor: Children's National Research Institute | Conditions: Anxiety, Depressive Symptoms | NA | Status: COMPLETED